Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Journal of Occupational Rehabilitation|February 24, 2024
Patterns of Mental Health Service Use in Australian Workers with Low Back Pain: A Retrospective Cohort StudyS E Gray, M Di Donato, L R Sheehan, et al.Psychotherapy (Chicago, Ill.)|October 19, 2018
A meta-analysis of the association between patients' early perception of treatment credibility and their posttreatment outcomesMichael J Constantino, Alice E Coyne, James F Boswell, et al.Prenatal Diagnosis|May 1, 1997
Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks' gestation)M C Macintosh, K H Nicolaides, P Noble, et al.Frontiers in Oncology|March 11, 2022
Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic LeukemiaXue Yi, Nitin Jain, LaKesla R Iles, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 22, 1999
Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRSJ Rico-Sanz, E L Thomas, G Jenkinson, et al.International Journal of Oncology|May 11, 2011
Serum placental-type alkaline-phosphatase levels in patients with epithelial ovarian-carcinomaT Ind, R Iles, K Desouza, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2007
Interaction between playing golf and HRT on vertebral bone properties in post-menopausal women measured by QCTP Eser, J Cook, J Black, et al.Pediatric Pulmonology|February 21, 2008
A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthmaR Iles, R M Williams, R W Williams, et al.Blood Advances|July 5, 2024
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinibBurcu Aslan, Ganiraju Manyam, Lakesla R Iles, et al.Prenatal Diagnosis|March 1, 1994
Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeksM C Macintosh, R Iles, B Teisner, et al.Pageof 5